JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32109

Anti-Bag1 antibody [Y166]

5

(4 Reviews)

|

(14 Publications)

Rabbit Recombinant Monoclonal BAG1 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 14 publications.

View Alternative Names

HAP, BAG1, BAG family molecular chaperone regulator 1, BAG-1, Bcl-2-associated athanogene 1

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-Bag1 antibody [Y166] (AB32109)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Bag1 antibody [Y166] (AB32109)

Immunofluorescent staining of HeLa cells using ab32109 at 1/100 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bag1 antibody [Y166] (AB32109)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bag1 antibody [Y166] (AB32109)

Immunohistochemical analysis of paraffin-embedded human prostate carcinoma using ab32109 at 1/100 dilution.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Western blot - Anti-Bag1 antibody [Y166] (AB32109)
  • WB

Lab

Western blot - Anti-Bag1 antibody [Y166] (AB32109)

Western blot : Anti-Bag1 antibody [Y166] ab32109 staining at 1/500 dilution, shown in green; Mouse anti alpha Tubulin ab7291 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 32 kDa in Wild-type A549 cell lysates with no signal observed at this size in BAG1 knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-Bag1 antibody [Y166] (ab32109) at 1/500 dilution

Lane 1:

Wild-type A549 at 20 µg

Lane 2:

BAG1 knockout A549 at 20 µg

Lane 3:

THP-1 at 20 µg

Lane 4:

HT1080 at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 39 kDa

Observed band size: 32 kDa,51 kDa

true

Exposure time: 8s

Western blot - Anti-Bag1 antibody [Y166] (AB32109)
  • WB

Unknown

Western blot - Anti-Bag1 antibody [Y166] (AB32109)

All lanes:

Western blot - Anti-Bag1 antibody [Y166] (ab32109) at 1/500 dilution

All lanes:

HeLa cell lysate

Predicted band size: 39 kDa

Observed band size: 33 kDa,46 kDa,50 kDa

false

Western blot - Anti-Bag1 antibody [Y166] (AB32109)
  • WB

CiteAb

Western blot - Anti-Bag1 antibody [Y166] (AB32109)

Bag1 western blot using anti-Bag1 antibody [Y166] ab32109. Publication image and figure legend from Wood, R. J., Ormsby, A. R., et al., 2018, Nat Commun, PubMed 29348634.

ab32109 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab32109 please see the product overview.

Probing changes in proteostasis through selective activation of different chaperone systems. a Investigation of the effect of induction of the heat shock response by HSF1 overexpression or selective overexpression of HSP90. Shown on left are western blots of the HEK293T cells matched for total protein via a BCA assay. These cells were co-transfected with HSF1 (or myc-tagged HSP90 or control of (non-fluorescent) Y66L Emerald fluorescent protein) and the L89G barnase biosensor (which also contains a myc tag). The right graphs show the Lower-slope and A50% analyses of these treatments and one or three of the biosensor variants as indicated vs. the wild-type* variant. Bars indicate means ± SEM. The right panels were analysed via a two-way ANOVA subjected to a Dunnett's post-hoc test, results coded as ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, ns = > 0.05. b Same paradigm as panel a. In this case, BAG1 was cotransfected with the barnase biosensor, HSP40 (DNAJB1) and HSP70 (HSPA1A). The right panels show the proportional dosage of each construct (by mass of DNA) in the transfection. Bars indicate means ± SEM. The right panel Lower-slope graph was analysed via a two-way ANOVA subjected to Dunnett's post hoc test and the A50% graph was analysed via a one-way ANOVA subjected to a Tukey's post-hoc test. Results coded as ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, ns = > 0.05

false

  • Carrier free

    Anti-Bag1 antibody [Y166] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

Y166

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The antibody should recognize all three isoforms of Bag-1 (Bag-1L, Bag-1M and Bag-1S).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Bag1 protein also known as Bcl-2-associated athanogene 1 has a molecular mass of approximately 46 kDa. The protein is ubiquitously expressed in various tissues and cells indicating its broad functional significance. Bag1 serves as a co-chaperone interacting directly with heat shock protein 70 (Hsp70) to modulate its activity. This interaction affects the protein folding process ensuring cellular proteins maintain their proper conformation.
Biological function summary

Bag1 plays essential roles in regulating cell survival and apoptosis. It can exist as part of a larger protein complex and is known to bind with the anti-apoptotic protein Bcl-2 enhancing cell survival. By interacting with these proteins Bag1 helps control the delicate balance between cell death and survival critical for normal cellular function and response to stress. Bag1 also affects transcription regulation cell cycle progression and cellular response to stress stimuli.

Pathways

Bag1 integrates into cellular stress response and apoptotic signaling pathways. Bag1's interaction with Hsp70 associates it with the heat shock response pathway which upregulates molecular chaperones to protect cells during stress. Additionally its binding to Bcl-2 situates it within the apoptotic pathway where it supports cell survival by inhibiting caspase activation. The protein further interacts with key regulatory proteins like Raf-1 linking it to the MAPK/ERK signaling pathway involved in cell growth and division.

Dysregulation of Bag1 connects to cancer development and neurodegenerative diseases. Overexpression of Bag1 has associations with cancers such as breast cancer where it promotes tumor growth by inhibiting apoptosis. Bag1's ability to interact with the Bcl-2 protein makes it a significant player in cancer pathways. Additionally changes in Bag1 expression and function have been observed in Alzheimer's disease highlighting its role in neuron survival and stress response. Bag1's involvement with proteins like Hsp70 and Bcl-2 highlights its potential as a therapeutic target in these conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Co-chaperone for HSP70 and HSC70 chaperone proteins. Acts as a nucleotide-exchange factor (NEF) promoting the release of ADP from the HSP70 and HSC70 proteins thereby triggering client/substrate protein release. Nucleotide release is mediated via its binding to the nucleotide-binding domain (NBD) of HSPA8/HSC70 where as the substrate release is mediated via its binding to the substrate-binding domain (SBD) of HSPA8/HSC70 (PubMed : 24318877, PubMed : 27474739, PubMed : 9873016). Inhibits the pro-apoptotic function of PPP1R15A, and has anti-apoptotic activity (PubMed : 12724406). Markedly increases the anti-cell death function of BCL2 induced by various stimuli (PubMed : 9305631). Involved in the STUB1-mediated proteasomal degradation of ESR1 in response to age-related circulating estradiol (17-beta-estradiol/E2) decline, thereby promotes neuronal apoptosis in response to ischemic reperfusion injury (By similarity).
See full target information BAG1

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

Cell discovery 11:19 PubMed40038243

2025

RNA cytidine acetyltransferase NAT10 maintains T cell pathogenicity in inflammatory bowel disease.

Applications

Unspecified application

Species

Unspecified reactive species

Haixin Li,Xuemin Cai,Changfen Xu,Xinhui Yang,Xiaohan Song,Yuxin Kong,Mei Yang,Qielan Wu,Song Guo Zheng,Yiming Shao,Ping Wang,Jing Zhou,Hua-Bing Li

Cell reports 42:113529 PubMed38060380

2023

Molecular determinants of the crosstalk between endosomal microautophagy and chaperone-mediated autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Gregory J Krause,Philipp Kirchner,Barbara Stiller,Kateryna Morozova,Antonio Diaz,Kuei-Ho Chen,Nevan J Krogan,Esperanza Agullo-Pascual,Cristina C Clement,Kristen Lindenau,Danielle L Swaney,Shilpa Dilipkumar,Jose Javier Bravo-Cordero,Laura Santambrogio,Ana Maria Cuervo

Analytical cellular pathology (Amsterdam) 2023:4500810 PubMed38077523

2023

Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Tongda Xu,Yuanyuan Zhang,Gege Liao,Haochen Xuan,Jie Yin,Jieli Bao,Yang Liu,Dongye Li

Biomedicines 11: PubMed36979842

2023

Bag-1 Protects Nucleus Pulposus Cells from Oxidative Stress by Interacting with HSP70.

Applications

Unspecified application

Species

Unspecified reactive species

Kaori Suyama,Daisuke Sakai,Shogo Hayashi,Ning Qu,Hayato Terayama,Daisuke Kiyoshima,Kenta Nagahori,Masahiko Watanabe

Journal of Cancer 12:4780-4790 PubMed34234849

2021

ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Feifei Fan,Ruxue Yin,Liuya Wang,Shunxin Zhao,Dan Lv,Kangli Yang,Shen Geng,Ningning Yang,Xiaohong Zhang,Hongmin Wang

Journal of neurochemistry 158:358-372 PubMed33025573

2020

Bag-1 mediates glucocorticoid receptor trafficking to mitochondria after corticosterone stimulation: Potential role in regulating affective resilience.

Applications

Unspecified application

Species

Unspecified reactive species

Shaolei Luo,Yangyang Hou,Yaping Zhang,Lei Feng,Richard G Hunter,Peixiong Yuan,Yue Jia,Haoran Li,Gang Wang,Husseini K Manji,Bruce S McEwen,Chunjie Xiao,Hongkun Bao,Jing Du

Bioscience reports 39: PubMed31189742

2019

LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jin-Tian Miao,Jian-Hua Gao,Yong-Qian Chen,Hong Chen,Hao-Yi Meng,Ge Lou

BMC cancer 19:258 PubMed30902071

2019

Interaction between the BAG1S isoform and HSP70 mediates the stability of anti-apoptotic proteins and the survival of osteosarcoma cells expressing oncogenic MYC.

Applications

Unspecified application

Species

Unspecified reactive species

Victoria J Gennaro,Helen Wedegaertner,Steven B McMahon

Oncology reports 41:1901-1910 PubMed30747221

2019

Downregulation of BAG‑1 in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Su Lu,Yiyi Du,Fang Cui,Xinyi Feng,Yuanyuan Ma,Hong Liu

Molecular medicine reports 17:7435-7441 PubMed29568970

2018

miR‑494‑BAG‑1 axis is involved in cinobufacini‑induced cell proliferation and apoptosis in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zhili Shen,Yan Li,Chengcheng Zhao,Fen Wang,Rongping Zhou,Gang Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com